At the heart of this innovative approach is an algorithm developed by Prof. Alexander Meyer, physician and computer scientist at the German Heart Center Berlin (DHZB) and cofounder of x-cardiac. The software collates data from various monitoring instruments in modern intensive care units and evaluates them intelligently, allowing potential critical complications, such as post-operative bleeding or acute kidney injury, to be detected much earlier than previously. This gives hospital staff the chance to intervene on time with appropriate therapeutic measures. In addition, Prof. Meyer hopes that the product can significantly reduce the average patient stay in intensive care units.
Using the stored and anonymized data of more than 50,000 patients, this software has been trained and tested in the intensive care units of the DHZB in real hospital operations since April 2018. x-cardiac intends to use the seed funding to have its first medical product "x-c-bleeding" for postoperative bleeding certified and marketed. A second medical product "x-c-renal-injury" for acute kidney failure is to follow.
The Berlin Institute of Health (BIH) and Charité – Universitätsmedizin Berlin have provided essential support for the development of this technology. A stipend from the BIH Charité Clinician Scientist Program allowed Alexander Meyer to devote half of his working hours to research. Additional BIH funding programmes have made a significant contribution towards the validation of the project, its transfer to clinical use, and preparations for founding the company.
Ascenion GmbH, technology transfer partner of Charité and BIH, holds equity in x-cardiac and will continue to support the company as required.
Further information:
- BIH press release: x-cardiac
- DHZB press release: financing x-cardiac (only in German)